Edwards Lifesciences (BSP:E1WL34) YoY EBITDA Growth : -1.60% (As of Mar. 2024)

View and export this data going back to 2020. Start your Free Trial

What is Edwards Lifesciences YoY EBITDA Growth?

YoY EBITDA Growth is the percentage change of EBITDA per Share over the past twelve months. Edwards Lifesciences's YoY EBITDA Growth for the quarter that ended in Mar. 2024 was -1.60%.

Edwards Lifesciences's EBITDA per Share for the three months ended in Mar. 2024 was R$3.93.

Edwards Lifesciences YoY EBITDA Growth Historical Data

The historical data trend for Edwards Lifesciences's YoY EBITDA Growth can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Edwards Lifesciences YoY EBITDA Growth Chart

Edwards Lifesciences Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

YoY EBITDA Growth

Get a 7-Day Free Trial

56.33

2.87

96.35

-2.61

-12.55

Edwards Lifesciences Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
YoY EBITDA Growth	Get a 7-Day Free Trial															5.61	-0.10	-9.85	-30.68	-1.60

Edwards Lifesciences YoY EBITDA Growth Calculation

YoY EBITDA Growth is the percentage change of EBITDA per Share over the past twelve months.

Edwards Lifesciences's YoY EBITDA Growth for the fiscal year that ended in Dec. 2023 is calculated as:

	YoY EBITDA Growth (A: Dec. 2023 )
=	(EBITDA per Share (A: Dec. 2023 )	-	EBITDA per Share (A: Dec. 2022 ))	/	\| EBITDA per Share (A: Dec. 2022 ) \|
=	(14.156	-	16.187)	/	\| 16.187 \|
=	-12.55 %

Edwards Lifesciences's YoY EBITDA Growth for the quarter that ended in Mar. 2024 is calculated as:

	YoY EBITDA Growth (Q: Mar. 2024 )
=	(EBITDA per Share (Q: Mar. 2024 )	-	EBITDA per Share (Q: Mar. 2023 ))	/	\| EBITDA per Share (Q: Mar. 2023 )) \|
=	(3.925	-	3.989)	/	\| 3.989 \|
=	-1.60 %

Edwards Lifesciences YoY EBITDA Growth Related Terms

Thank you for viewing the detailed overview of Edwards Lifesciences's YoY EBITDA Growth provided by GuruFocus.com. Please click on the following links to see related term pages.

Edwards Lifesciences (BSP:E1WL34) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Edwards Lifesciences Corp (BSP:E1WL34) » Definitions » YoY EBITDA Growth

Comparable Companies

Traded in Other Exchanges

EW:USA EW:Mexico 1EW:Italy EWL:Germany EWLS:Austria

Address

One Edwards Way, Irvine, CA, USA, 92614

Website

https://www.edwards.com

Spun off from Baxter International in 2000, Edwards Lifesciences designs, manufactures, and markets a range of medical devices and equipment for advanced stages of structural heart disease. It has established itself as a leader across key products, including surgical tissue heart valves, transcatheter valve technologies, surgical clips, catheters, and monitoring systems used to measure a patient's heart function during surgery. The firm derives about 55% of its total sales from outside the U.S.

Edwards Lifesciences (BSP:E1WL34) Headlines

No Headlines